On April 23, Roth lowered its 12-month price target on Tesla (TSLA) to $395 from $450 due to a reduced 2025 revenue forecast ...

In his April 21 first-quarter preview, Rohit Kulkarni, Senior Research Analyst at Roth Capital Partners maintained his “Buy” ...

AudioEye (NASDAQ: AEYE) , the industry-leading digital accessibility company, previously announced the pricing of the underwritten secondary offering ...

SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

In recent days, the wild swings in US stocks, largely driven by President Donald Trump’s repeated U-turns on tariffs, have ...

Aptevo Therapeutics (APVO) announced that it has entered into definitive securities purchase agreements for the purchase and sale of 2,324,000 ...

"The on-again off-again is particularly destabilizing for the industry, and that has certainly led to there being a bit more ...

Tesla execs talked affordable models, tariffs, DOGE, and more. Investors were more optimistic — at least temporarily.

Asure Software (NASDAQ: ASUR) , a provider of integrated software solutions, has announced its entry into a significant financial agreement, securing ...

The Trump administration’s China tariffs have piled atop existing and developing trade barriers on battery energy storage systems, components, and materials – destabilizing the US energy storage ...

Antalpha Platform Holding has filed for an initial public offering with the Securities and Exchange Commission.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...